Device Firms’ ‘Vaginal Rejuvenation’ Marketing Claims Spark US FDA Response
Executive Summary
US FDA sent letters to seven laser and ablation product manufacturers that have been marketing their products’ ability to provide "vaginal rejuvenation," or treat sexual dysfunction – claims that Commissioner Scott Gottlieb said have not been cleared or approved.
You may also be interested in...
FDA Looks To Lead World In Post-Market Device Surveillance With Safety Plan, Investments
US FDA Nov. 20 announced plans for a broad series of updates to its Medical Device Safety Action Plan for the next several months, with the goal that FDA "is consistently first among the world’s regulatory agencies to identify and act upon safety signals related to medical devices.
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.
HHS Secretary Nominee Becerra Commits To Telehealth Expansion, Procedure Price Transparency
At two recent confirmation hearings, HHS secretary nominee Xavier Becerra promised Senators he would help expand telehealth and procedure price transparency.